Adjuvant Carcinoma of the Colorectal
ECOG E5204
Phase III Study of Postoperative Oxaliplatin, 5FU and Leucovorin vs Oxaliplatin, 5FU, Leucovorin and Bevacizumab for patients with Stage II or III Rectal Cancer Receiving Pre-Op Chemoradiation

ECOG E5202
A Randomized, Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers

CINJOG 070501 (1st line Metastatic Pancreatic Cancer)
Gemzar & Gleevec

ECOG E4203
Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients with Metastatic Colorectal Cancer

ECOG N0147
Stage III Colon Cancer after Curative resection Phase III trial FOLFOX with or without Cetuximab